Will SPRINT change my practice? SPRINT: a randomised trial of intensive versus standard blood-pressure control

EuroIntervention 2016;12:809-812. DOI: 10.4244/EIJV12I6A132

Sebastian Ewen
Sebastian Ewen1*, MD; Melvin D. Lobo2, MD; Atul Pathak3, MD; Roland E. Schmieder4, MD; Costas Tsioufis5, MD; William Wijns6,7, MD; Felix Mahfoud1, MD
1. Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany; 2. William Harvey Research Institute and Barts NIHR Cardiovascular Biomedical Research Unit, Queen Ma

Introduction to the session

The aim of the summary report is to capture the session at EuroPCR 2016 that reviewed the implications for clinical practice of SPRINT (Systolic Blood Pressure Intervention Trial)1, in order to share the critical analysis of the trial and report the views expressed in the interactive discussion. This article does not constitute an independent review of the topic by the authors.

SPRINT certainly addresses a clinically relevant problem in attempting to improve the definition of optimal targets for systolic blood pressure (SBP) lowering in a hypertensive population at varying levels of cardiovascular risk. However, ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Interventions for hypertensionOther hypertension
Read next article
Meta-analysis: don’t do what I did

Latest news